KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $428 | +27.8% | 3,687 | +29.1% | 0.03% | +26.9% |
| Q2 2023 | $335 | +20.1% | 2,857 | -18.1% | 0.03% | +30.0% |
| Q1 2023 | $279 | +9.0% | 3,488 | +8.1% | 0.02% | -4.8% |
| Q4 2022 | $256 | -99.9% | 3,228 | -10.1% | 0.02% | -8.7% |
| Q3 2022 | $250,000 | 0.0% | 3,591 | -5.7% | 0.02% | 0.0% |
| Q2 2022 | $250,000 | +25.0% | 3,808 | +26.5% | 0.02% | +228.6% |
| Q1 2022 | $200,000 | – | 3,011 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |